Cognition Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: CGTX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1455365
| Field | Detail |
|---|---|
| Company | Cognition Therapeutics INC (CGTX) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: CTXI
TL;DR
CTXI filed an 8-K about a shareholder vote. Details TBD.
AI Summary
Cognition Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of security holders as of June 18, 2025. The filing does not contain specific details about the vote itself, such as proposals or outcomes.
Why It Matters
This filing indicates that Cognition Therapeutics held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- Cognition Therapeutics, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- June 20, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 001-40886 (identifier) — SEC file number
FAQ
What specific matters were submitted to a vote of Cognition Therapeutics' security holders?
The filing does not specify the exact proposals or matters that were submitted to a vote of security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on June 18, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed on June 20, 2025.
What is the principal executive office address for Cognition Therapeutics, Inc.?
The principal executive offices are located at 2500 Westchester Avenue, Purchase, NY 10577.
What is the SEC file number for Cognition Therapeutics, Inc.?
The SEC file number for Cognition Therapeutics, Inc. is 001-40886.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding COGNITION THERAPEUTICS INC (CGTX).